JPS61268138A - Production of modified whey protein concentrate - Google Patents
Production of modified whey protein concentrateInfo
- Publication number
- JPS61268138A JPS61268138A JP11052485A JP11052485A JPS61268138A JP S61268138 A JPS61268138 A JP S61268138A JP 11052485 A JP11052485 A JP 11052485A JP 11052485 A JP11052485 A JP 11052485A JP S61268138 A JPS61268138 A JP S61268138A
- Authority
- JP
- Japan
- Prior art keywords
- whey
- protein concentrate
- milk
- precipitate
- whey protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Dairy Products (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は改質ホエー蛋白濃縮物の製造法に関するもので
ある。DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to a method for producing a modified whey protein concentrate.
更に詳細には、本発明は、β−ラクトグロブリンが低減
されてなる改質蛋白濃縮物の製造法に関するものである
。More specifically, the present invention relates to a method for producing a modified protein concentrate with reduced β-lactoglobulin.
(従来技術〕
一般に、チーズ製造において生成するホエーは牛乳中の
脂肪とカゼインを除く大部分の水溶性成分を含有してい
る。ホエー中に大量に含まれる乳糖は、ホエーから゛容
易に結晶化され1分離されて食用や薬用に利用されてき
た。(Prior art) In general, whey produced in cheese production contains most of the water-soluble components in milk, except for fat and casein. It has been isolated and used for food and medicine.
そして、過剰の乳糖を分離し、更に残存する塩類を脱塩
によシ分離除去したホエー蛋白濃縮物は、多くの場合そ
のま\の状態で食品素材として利用されているが、含有
されている各種蛋白質の特徴を生かした高度の有効利用
はなされていない。Whey protein concentrate, which is obtained by separating excess lactose and removing remaining salts by desalting, is often used as a food material as is, but it contains Highly effective utilization that takes advantage of the characteristics of various proteins has not been made.
その理由の1つとしてホエー中の蛋白にはβ−ラクトグ
ロブリン(以下β−Lgと記す)が多量に存在している
ことが挙げられる。即ちホエー蛋白を青光用食品調製物
と蛋白源として利用することは、乳児の蛋白利用効率上
好ましいが、β−Lgは母乳にはほとんど存在しない蛋
白であり、乳児の個体差によってはアレルゲンとして作
用することもある。One of the reasons for this is that whey contains a large amount of β-lactoglobulin (hereinafter referred to as β-Lg). In other words, using whey protein as a protein source in food preparations for blue light is preferable in terms of protein utilization efficiency for infants, but β-Lg is a protein that hardly exists in breast milk, and may be used as an allergen depending on individual differences in infants. Sometimes it works.
それ故β−Lgを低減或は除去したホエー蛋白を得るこ
とは工業生産技術として期待されるところであった。Therefore, it has been expected as an industrial production technology to obtain whey protein with reduced or eliminated β-Lg.
そこで、従来、ホエーからβ−ラクトグロブリンを除去
してホエー蛋白の有効利用をはかろうとする試みが多く
なされている。次に、それらの公知技術及びその問題点
を列記する。Therefore, many attempts have been made to remove β-lactoglobulin from whey in order to effectively utilize whey protein. Next, those known techniques and their problems will be listed.
1、 高分子多荷゛亀解質による共沈法〔ジエー・ヒダ
ルゴ(J、 Hidalgo ) 4ジヤーナル・オブ
・デアリー・サイエンス(J、 Dairy Sci
)、、 54゜1270 (1971)並にエヌ・メラ
コウリス(N。1. Co-precipitation method using polymer-rich turtle solute [J, Hidalgo] 4 Journal of Dairy Science (J, Dairy Sci)
),, 54°1270 (1971) and N. Melakouris (N.
Melachouris )によるジャーナル・オブ・
アグリカルチュラル・フード・ケミストリー(J、 A
gr。Journal of
Agricultural Food Chemistry (J, A
gr.
Food Chem )−、20,798(1972)
)これらの方法は添加した藁分子多荷電解質の濃度と
声の調整によってα−ラクトグロブリン(以下α−La
と記す)とは反応させないでβ−Lgと共沈分離させる
方法である。Food Chem)-, 20,798 (1972)
) These methods are based on α-lactoglobulin (hereinafter α-La
) is a method of co-precipitation separation with β-Lg without reaction.
この方法の問題点は、共沈に当り微量ではあるが、異物
買成分である高分子多荷電購買の残留があり好ましくな
い。The problem with this method is that during coprecipitation, a small amount of highly charged polymer particles, which are foreign substances, remain, which is not preferable.
2 塩析法 〔シエー・マツクチ−・アームストロング(J。2 Salting out method [Shea Matsukuchi Armstrong (J.
McD、 Armstrong )等7暑イオヒミカ・
エトアル・バイオフイジカ(Biochimica e
t Biophysica+エイシーチーニー(ACT
A)147巻60ページこの方法においては、乳ホエー
において塩類を添加した場合、α−Laとβ−Lgとは
溶解度が異な、9.p)13.5において硫酸アンモニ
ウム濃度約27チでα−Laは沈澱し、β−Lgは溶解
している。McD, Armstrong) etc. 7 Hot Iohimika・
Biochimica e
t Biophysica+AC Cheney (ACT
A) Volume 147, page 60 In this method, when salts are added to milk whey, α-La and β-Lg have different solubility; 9. At p) 13.5, α-La is precipitated and β-Lg is dissolved at an ammonium sulfate concentration of about 27%.
これを濾過或は遠心により分別するという方法である。The method is to separate this by filtration or centrifugation.
この方法では、高純度の分離採取に適するが硫酸アンモ
ニウムを多量に使用するためにコスト高となυ工業的手
段とはなり得ない。Although this method is suitable for high-purity separation and collection, it cannot be an industrial means because it uses a large amount of ammonium sulfate and is expensive.
五 分子篩分別法〔ニー・リングクイスト(A。5. Molecular sieve fractionation method [Nie Ringquist (A.
Ljungquist )等プレパラテイプ・バイオケ
ミスト リ − (Preparative Bio
chemistry )”l 5 : 131
゜この方法は分子量の差によってゲル濾過、或は限外濾
過によって分別するもので、例えば平均の分画分子量が
25,000程度の膜でホエーを処理すればβ−Lgは
濃縮され、α−Laは濾過分離する。Preparative Biochemistry (Ljungquist) etc.
chemistry)”l 5: 131
゜This method separates whey by gel filtration or ultrafiltration based on the difference in molecular weight. For example, if whey is treated with a membrane with an average molecular weight cut-off of about 25,000, β-Lg will be concentrated, and α-Lg will be concentrated. La is separated by filtration.
然し現実の問題として検討の結果、工業的に使用する膜
の孔のサイズにはバラツキがあシ、適確な分別は困難で
あった。またゲル濾過ではゲル材が高価であることと、
カラム内での各檀トラブルが発生し、好ましくなかった
。However, as a result of examination as a practical problem, it was found that the pore sizes of industrially used membranes vary, making accurate separation difficult. Also, in gel filtration, the gel material is expensive,
Various troubles occurred within the column, which was not desirable.
4、 イオン交換クロマトグラフィー法〔ヤグチ(Ya
guchi )等、ジャーナル・オプ・デアリー・サイ
エンス(J、 Dairy 5cience )、、
44巻:589水沫はホエーをイオン交換体の層に通液
し静電的な力によって担体にたん白を吸着させる。次に
この吸着たん白を適切な塩濃度勾配或は−勾配によって
溶出展開させα−Laとβ−Lgを分別採取する方法で
ある。4. Ion exchange chromatography method [Yaguchi
guchi) et al., Journal of Dairy Science (J, Dairy 5science),
Volume 44: 589 Water droplets pass whey through a layer of ion exchanger and adsorb proteins onto the carrier using electrostatic force. Next, this adsorbed protein is eluted and developed using an appropriate salt concentration gradient or -gradient, and α-La and β-Lg are separated and collected.
この方法は、比較的実用性のある方法であるが樹脂の価
格が隔<、樹脂の汚れ、再生上に問題がある。Although this method is relatively practical, there are problems with the price of the resin, staining of the resin, and recycling.
5、等電点分離法〔シー・エッチ・アムンドソン(C,
H,Amundson )、ホエー・プロダクツ・コン
ファレンス(Whey Products Confe
rence )オクト−バー(0ctober ) 2
1〜22 (1980)シカゴ・イリノイス(Chic
ago l1linois ) )この方法は本発明と
類似する点もある。一般に可溶性たん白は、分子内に多
数の極性基を有しておシ1等電点pHにおいて溶解度は
最小となる。このとき溶液中に塩類が存在するとそれら
の陰・老イオンが蛋白の極性基と結合してその溶解度に
影響を与えることになる。ホエー蛋白の場合α−Laも
β−Lgも等電点pHは4.5付近であシこの−におい
て塩濃度或は溶液温度を調整することによって両者を分
別することができる。同文献の7頁では、ホエーをUP
濃縮し、pifを4.65に調整し。5. Isoelectric focusing method [C. H. Amundson (C,
H. Amundson), Whey Products Conference
rence ) October (0ctober) 2
1-22 (1980) Chicago Illinois
ago llinois)) This method has some similarities with the present invention. Generally, soluble proteins have a large number of polar groups in their molecules, and have a minimum solubility at the isoelectric point pH. At this time, if salts are present in the solution, these anions and old ions will bond with the polar groups of the protein and affect its solubility. In the case of whey protein, the isoelectric point pH of both α-La and β-Lg is around 4.5, and the two can be separated by adjusting the salt concentration or solution temperature. On page 7 of the same document, whey is UP
Concentrate and adjust pif to 4.65.
電気透析脱塩し、更Kp)1を4.65に再調整して生
ずる沈澱を脱β−Lg画分として遠心分離したと記して
いる。しかし、この方法は加熱工程を含まない点及び脱
β−Lg 1IJIi分を上溝としている点で本発明と
は根本的に異なるものである。更にこの方法を実験によ
って追試した結果では、α−Laとβ−Lgとの明確な
分離ができなかった。It is described that the precipitate obtained by electrodialytic desalting and readjustment of Kp)1 to 4.65 was centrifuged as a de-β-Lg fraction. However, this method is fundamentally different from the present invention in that it does not include a heating step and that the amount of β-Lg 1IJIi removed is used as the upper groove. Further, as a result of experimenting with this method, it was not possible to clearly separate α-La and β-Lg.
(発明の構成)
本発明は乳ホエー又は乳ホエー蛋白濃縮物から無機塩類
を90%以上除去脱塩し、得られた脱塩液の田を3.6
〜5.0に調整し1次いで一調整液を40〜80℃に加
熱し、生成した沈澱部分を採取することを特徴とするβ
−Lgが低減されてなる改質蛋白濃縮物の製造法である
。(Structure of the Invention) The present invention desalinates milk whey or milk whey protein concentrate by removing 90% or more of inorganic salts, and collects the resulting desalted solution by 3.6 ml.
- 5.0, then heating the adjusted solution to 40 to 80°C, and collecting the precipitate produced.
- A method for producing a modified protein concentrate with reduced Lg.
(発明が解決しようとする問題点)
人乳と牛乳の蛋白画分を分析例に基いて比較すると衣−
1の通りである。(Problem to be solved by the invention) When comparing the protein fractions of human milk and cow's milk based on analysis examples,
As per 1.
表−1から明らかなように、牛乳ではカセインの栴成比
が人乳に比較して著しるしく大きく、また、牛乳にはβ
−Lgが14.8%も含まれているが1人乳には全く含
まれていないことも分る。As is clear from Table 1, the concentration ratio of casein in cow's milk is significantly higher than that in human milk;
It can also be seen that human milk contains 14.8% of -Lg, but human milk does not contain it at all.
また表−1からはβ−Lgが時として乳児のアレルゲン
となることもちゃ得るのでホエーを育児用調製物に利用
しようとするときは、可能な限シβ−Lgが除去或は減
少されたホエー蛋白濃縮物として使用することがのぞま
しいと言うべきである。Table 1 also shows that β-Lg can sometimes be an allergen for infants, so when whey is to be used in infant preparations, β-Lg should be removed or reduced as much as possible. It should be said that it is preferable to use it as a whey protein concentrate.
(問題点を解決するための手段)
本発明では、まず、乳ホエー又は乳ホエー蛋白濃縮物か
ら無機塩類を90%以上、好ましくは9日チ以上除去脱
塩する。脱塩にはイオン交換樹脂、例えば陽イオン交換
樹脂と陰イオン交換樹脂の混合カラム、を使用するのが
よい。無機塩類の脱塩が90%以上であると、α−La
の沈澱率を60チ以上に高め、脱塩が98優以上である
と、α−Laの沈澱率を9υチ以上に高めることができ
る。(Means for Solving the Problems) In the present invention, first, milk whey or milk whey protein concentrate is desalted to remove 90% or more of inorganic salts, preferably for 9 days or more. For desalting, it is preferable to use an ion exchange resin, such as a mixed column of cation exchange resin and anion exchange resin. When the desalination of inorganic salts is 90% or more, α-La
If the precipitation rate of α-La is increased to 60 or more and the desalination is 98 or more, the precipitation rate of α-La can be increased to 9 or more.
次いで、脱塩液を丙を3.6〜5.0に好ましくはpH
4,2〜4.4に調整する。Then, the desalination solution is adjusted to a pH of preferably 3.6 to 5.0.
Adjust to 4.2 to 4.4.
一般に、ホエーはpti+41j程度であシ、これをイ
オン交換樹脂によって98チ程度脱塩すると聞はほぼ4
.0に低下する。この脱塩ホエー液をpti&6〜5.
0.好ましくはpli4.2〜4.4に調整する。pi
(3,6〜5.0で、加熱によって55チ以上のα−L
aの沈澱は得られるが、pt14.2〜4.4の調整で
は80チ以上のα−Laの沈澱が得られる。Generally, whey has a pti of about 41j, and when this is desalted using an ion exchange resin, it has a pti of about 41j.
.. decreases to 0. Pti&6~5.
0. Preferably, pli is adjusted to 4.2 to 4.4. pi
(3.6 to 5.0, α-L of 55 inches or more by heating
A precipitate of α-La is obtained, but when the pt is adjusted to 14.2 to 4.4, a precipitate of 80 or more α-La is obtained.
メi3.6〜5.0の脱塩液は40〜80°C1好まし
くは45〜70℃に加熱する。加熱した液はそのままの
温度で1時間程度放置すると、α−Laの沈澱が生成す
るので、これを遠心分離によってペースト状の沈澱物と
上清に分けることができる。The desalination solution with a mea of 3.6 to 5.0 is heated to 40 to 80°C, preferably 45 to 70°C. When the heated liquid is left at that temperature for about 1 hour, a precipitate of α-La is formed, which can be separated into a paste-like precipitate and a supernatant by centrifugation.
上清には大部分のβ−Lgと乳糖が移行存在しており、
この上清を限外瀝過膜法によって濃縮してゆくと乳糖及
び水は膜を透過し、β−Lg は膜に阻止されて、大部
分がβ−Lgからなる濃縮物を得ることができる。更に
これを濃縮、乾燥することによってβ−Lg製品を得る
ことができる。Most of β-Lg and lactose are present in the supernatant,
When this supernatant is concentrated using an ultrafiltration membrane method, lactose and water permeate through the membrane, and β-Lg is blocked by the membrane, making it possible to obtain a concentrate consisting mostly of β-Lg. . Further, by concentrating and drying this, a β-Lg product can be obtained.
他方、沈澱部分には大部分のα−La及びその他の乳蛋
白を含有しているが、β−Lgの含有率は極めて低い。On the other hand, the precipitate contains most of α-La and other milk proteins, but the content of β-Lg is extremely low.
沈澱物は水に溶解させ、アルカリで中性にして加熱殺菌
を行ない1次いで濃縮、乾燥し、β−Lg含有率の極め
て低いホエー蛋白鏝鰯物を粉状で調製することができる
。The precipitate is dissolved in water, neutralized with an alkali, heat sterilized, then concentrated and dried to prepare a powdered whey protein with an extremely low β-Lg content.
得られたホエー蛋白aMi物は、α−Lgをほとんど含
有していないので、乳児用詞製物やその他食品に蛋白原
料として有効に利用することができるものである。Since the obtained whey protein aMi product contains almost no α-Lg, it can be effectively used as a protein raw material for infant preparations and other foods.
次に本発明の試験例及び実施例を示す。Next, test examples and examples of the present invention will be shown.
試験例1゜
チーズホエー(…6.4)をイオン交換樹脂壜アンバー
ライト社製の陽イオン交換樹脂であるIR−120B及
び陰イオン交換樹脂であるIRA−410を充填した複
床式のカラム)に通液した。Test Example 1゜ Cheese whey (...6.4) was packed in an ion exchange resin bottle (double-bed column filled with IR-120B, a cation exchange resin, and IRA-410, an anion exchange resin manufactured by Amberlite) The liquid was passed through.
処理液は原液に比して98%脱塩されていた。この98
%脱塩液に未脱塩の原液を適宜溶液混合し50%、80
チ、90%、95チ、98%の5段階の脱塩度ホエーを
調製した。The treated solution was 98% desalted compared to the original solution. This 98
% Desalted solution and undesalted stock solution are mixed appropriately to give 50%, 80%
Five levels of desalinated whey were prepared: 1, 90%, 95%, and 98%.
5段階の脱塩度ホエーを用いて1%々のホエーの−を4
.6に調整し、それぞれ60℃に加熱し1時間保持した
後10,0OOG、10分間遠心分離し、沈澱部分を採
取した。こ\で得られた5槌類の沈澱部分を分析し、*
チーズホエー中のβ−Lgとα−Laが、どの程度沈澱
したかを調べた結果が$−2である。脱塩度は90%以
上、効率等を勘案し好ましくは98%程度が工業的に最
も迩すると判断された。Using 5 levels of desalinated whey, 1% of each whey is -4
.. 6, heated to 60°C, held for 1 hour, centrifuged at 10.0 OOG for 10 minutes, and collected the precipitate. Analyze the precipitate part of the 5 mallets obtained in this way, *
The result of examining the extent to which β-Lg and α-La in cheese whey precipitated was $-2. It has been determined that a degree of desalination of 90% or more, preferably about 98% in consideration of efficiency etc., is most suitable for industrial purposes.
試験例2
試験例1にて調製した98チ脱塩度のホエーを用いて、
これを5つに区分し、声を3.6,4.0゜4.6.4
.6.5.0の5段階に調整し、加熱条件。Test Example 2 Using the whey with a desalination degree of 98% prepared in Test Example 1,
This is divided into five parts, and the voices are 3.6, 4.0°4.6.4
.. Adjust the heating conditions to 5 stages of 6.5.0.
沈澱部分の採取方法は試験1と同一にして原ホエー中の
β−Lgとα−Laの沈澱率を調べた結果が表−3の通
りであシ、β−Lgの沈澱を押さえつつα−Laを高濃
度に沈澱させる本発明の目的に最も適する−は4.3附
近であることが確認された。The method of collecting the precipitate was the same as in Test 1, and the results of examining the precipitation rate of β-Lg and α-La in the raw whey are shown in Table 3. It was confirmed that the most suitable value for the purpose of the present invention, which is to precipitate La at a high concentration, is around 4.3.
なお内の調整には10%水酸化す) 17ウム及び10
チ塩酸を使用した。(10% hydroxide is used to adjust the contents) 17um and 10
Thihydrochloric acid was used.
試験例6゜
試験例1にて調製した98%脱塩度ホエーを声4.6に
調整し、これを加熱した。加熱条件を20℃、40℃、
60℃、70℃、80℃、100°Cの6段階として谷
温度にて60分間保持し、遠心分離して沈@部分を試験
1と同一にして採取した。Test Example 6 The 98% demineralized whey prepared in Test Example 1 was adjusted to a strength of 4.6 and heated. Heating conditions were 20℃, 40℃,
The mixture was maintained at trough temperature for 60 minutes in 6 steps of 60°C, 70°C, 80°C, and 100°C, centrifuged, and the precipitated portion was collected in the same manner as in Test 1.
原ホエー中のβ−Lgとα−Laの沈殿率を調べた結果
が表−4の通りである。β−Lg移行率の低い範囲でα
−Laの移行率が高い条件は、60°C附近であり、保
持時間を短縮すれば60℃〜80℃の温度領域において
もβ−Lgの移行率を低くおさえることはできたが、逆
にα−Laの沈澱率の増加はほとんど期待できないので
、求める沈澱部分の性状を考慮して60℃−60分保持
条件を実用上液も好ましいと判断した。Table 4 shows the results of investigating the precipitation rate of β-Lg and α-La in raw whey. β-α in the low range of Lg transfer rate
The condition for a high migration rate of -La is around 60°C, and if the holding time was shortened, the migration rate of β-Lg could be kept low even in the temperature range of 60°C to 80°C, but on the contrary, Since almost no increase in the precipitation rate of α-La can be expected, in consideration of the desired properties of the precipitated portion, it was determined that a holding condition of 60° C. for 60 minutes would be preferable for practical use.
実施例1゜
牛乳10,000Icgを処理してゴーダチーズを製造
する際に分離された−6.6のチーズホエー9,000
kgを使用し、全量をイオン交換塔に通過させた。Example 1 9,000 g of -6.6 cheese whey separated during the production of Gouda cheese by processing 10,000 Icg of milk
kg was used and the entire amount was passed through an ion exchange column.
イオン交換塔にはアンバーライト社製陽イオン交換樹脂
である1几−120と陰イオン交換樹脂である■几A−
410を複床式カラムに充填し、ホエーを流下通液した
。電気伝導度は通過前6000μη偽から通液後120
μ7f/cmまで低下し困は6.6から4.0に低下し
た。脱塩率は98%でめった。The ion exchange tower contains a cation exchange resin 1-120 manufactured by Amberlite and an anion exchange resin ■A-1.
410 was packed into a double-bed column, and whey was passed through the column. Electrical conductivity ranges from 6000μη false before passing to 120 after passing.
It decreased to μ7f/cm and the difficulty decreased from 6.6 to 4.0. The desalination rate was 98%.
得られた脱塩液の声を、10チ水酸化ナトリウムを用い
て4,25に調整した。The voice of the obtained desalted solution was adjusted to 4.25 using 10% sodium hydroxide.
得られたー調整液をジャケット加熱磯及び撹拌機をそな
えたタンク中で60℃に加熱し、1時間保持した。The resulting prepared solution was heated to 60° C. in a tank equipped with a jacketed heating stone and a stirrer, and maintained for 1 hour.
次いで、脱塩ホエーを40℃に冷却し、アルファラバル
社製MRPX−418型遠心分離機にて沈澱部分と上清
部分に分離した。このときの得られた沈澱部分と上清部
分の量及び分析値並に原料ホエーの分析値を表−5,6
,7に示す。Next, the desalted whey was cooled to 40° C. and separated into a precipitate portion and a supernatant portion using an Alfa Laval MRPX-418 centrifuge. Tables 5 and 6 show the amounts and analytical values of the precipitate and supernatant obtained at this time, as well as the analytical values of the raw material whey.
, 7.
表 −5(原料ホエー分析値)
表 −6(上清部分分析値)
得られた沈澱部分を10%NaOH液にて中和した後常
法に従って殺菌、濃縮、噴霧乾燥し、脱β−Lg、脱塩
、減乳糖の改質ホエー蛋白粉末を得た。Table 5 (Analysis values of raw whey) Table 6 (Analysis values of supernatant part) After neutralizing the obtained precipitate with 10% NaOH solution, sterilization, concentration, and spray drying were performed according to a conventional method to remove β-Lg. , a desalinated, lactose-reduced modified whey protein powder was obtained.
得られた改質ホエー蛋白粉末は育児用の粉乳、その他の
食品に添加利用される。The obtained modified whey protein powder is used as an additive to powdered milk for infants and other foods.
一方、上清部分は常法に従って殺菌、濃縮、乾燥してβ
−Lg画分の多い脱塩ホエー粉末を得ることができる。On the other hand, the supernatant portion was sterilized, concentrated, and dried according to conventional methods.
- Desalinated whey powder with a large Lg fraction can be obtained.
これは通常の乳成分特に栄養素材として食品製造用に利
用される。It is used as a normal milk ingredient, especially as a nutritional material, for food production.
なお、上記上清部分を殺菌し、限外濾過濃縮して過剰の
乳糖を濾過分離すればβ−Lg濃縮物が得られる。これ
は特殊な栄養素材として栄養食品製造用に有効に利用す
ることができる、。Note that a β-Lg concentrate can be obtained by sterilizing the supernatant portion, concentrating it by ultrafiltration, and separating excess lactose by filtration. This can be effectively used as a special nutritional material for the production of nutritional foods.
また、乳糖を精製採取する場合は、通常の方法で涙液を
濃縮、冷却、結晶化、遠心分離することによって目的物
を得る。When lactose is purified and collected, the desired product is obtained by concentrating, cooling, crystallizing, and centrifuging the lachrymal fluid using conventional methods.
(発明の効果)
本発明の方法によシ乳ホエー又は乳ホエー蛋白濃縮物か
ら製造した改質ホエー蛋白濃縮物は牛乳に較べてβ−L
gが極めて少なく、α−Laが比較的に多いため人乳中
のホエー蛋白の組成に近似しておシ、例えば本発明によ
る改質ホエー蛋白濃縮物の蛋白6部にカゼインの蛋白4
部を加えて可溶化し、脂質、糖質及びその他の微量成分
を添加して成分のバランスを人乳に近似させることによ
)従来実用化されていなかった蛋白の組成をも人乳に近
づけることが可能となったのである。(Effects of the Invention) The modified whey protein concentrate produced from milk whey or milk whey protein concentrate by the method of the present invention has a lower β-L content than milk.
Since the content of α-La is extremely low and α-La is relatively high, the composition approximates that of whey protein in human milk.For example, the modified whey protein concentrate according to the present invention contains 6 parts of protein and 4 parts of casein protein.
The composition of protein, which has not been put to practical use in the past, can also be brought close to that of human milk (by adding solubilized protein and adding lipids, carbohydrates, and other trace components to approximate the balance of ingredients to that of human milk). This became possible.
代理人 弁理士 戸 1)親 男 手続補正書(自発) 昭和60年7月2−6日Agent Patent Attorney 1) Parent Male Procedural amendment (voluntary) July 2-6, 1985
Claims (2)
90%以上除去脱塩し、得られた脱塩液のpHを3.6
〜5.0に調整し、次いでpH調整液を40〜80℃に
加熱し、生成した沈澱部分を採取することを特徴とする
β−ラクトグロブリンが低減されてなる改質蛋白濃縮物
の製造法。(1) Remove 90% or more of inorganic salts from milk whey or milk whey protein concentrate, and desalinate the resulting desalted solution to pH 3.6.
-5.0, then heating the pH-adjusted solution to 40-80°C, and collecting the generated precipitate. A method for producing a modified protein concentrate with reduced β-lactoglobulin. .
の範囲第1項記載の製造法。(2) The manufacturing method according to claim 1, wherein the desalting is desalting using an ion exchange resin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11052485A JPS61268138A (en) | 1985-05-24 | 1985-05-24 | Production of modified whey protein concentrate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11052485A JPS61268138A (en) | 1985-05-24 | 1985-05-24 | Production of modified whey protein concentrate |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61268138A true JPS61268138A (en) | 1986-11-27 |
JPH0360468B2 JPH0360468B2 (en) | 1991-09-13 |
Family
ID=14537983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11052485A Granted JPS61268138A (en) | 1985-05-24 | 1985-05-24 | Production of modified whey protein concentrate |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61268138A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0279940A (en) * | 1988-06-16 | 1990-03-20 | Unilever Nv | Endible plastic composition |
JPH02503425A (en) * | 1987-05-14 | 1990-10-18 | コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガナイゼーション | whey protein fraction |
JPH02303457A (en) * | 1989-05-19 | 1990-12-17 | Snow Brand Milk Prod Co Ltd | Food and medicine having osteogenesis promotive and bone resorption preventive effects |
US5093143A (en) * | 1990-01-26 | 1992-03-03 | Milchwerke Westfalen Eg | Dietetic nutrient compositions for patients with kidney insufficiency |
US5135869A (en) * | 1988-07-20 | 1992-08-04 | Meiji Milk Products Company Limited | Selective enzymatic degradation of β-lactoglobulin contained in cow's milk-serum protein |
JPH04267850A (en) * | 1991-02-25 | 1992-09-24 | Daiichi Kasei:Kk | Production of processed food of prepared milk serum protein |
JPH05236883A (en) * | 1992-02-18 | 1993-09-17 | Snow Brand Milk Prod Co Ltd | Production of fraction having high alpha-lactoalbumin content from whey and human milk substitute or nutritious composition containing the same fraction |
US5420249A (en) * | 1992-12-23 | 1995-05-30 | Campina Melkunie B.V. | Process for the recovery of α-lactalbumin and β-lactoglobulin from a whey protein product |
WO1995034216A1 (en) * | 1994-06-15 | 1995-12-21 | Pascont Technologies Limited | Process for the fractionation of whey constituents |
CN112770637A (en) * | 2018-06-27 | 2021-05-07 | 阿尔拉食品公司 | Novel method for preparing compositions enriched in alpha-lactalbumin, related products and use in e.g. infant formulas |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2150571C (en) * | 1992-11-30 | 1998-09-29 | Seiichi Shimamura | Low-phosphorus whey protein, manufacturing method thereof, low-phosphorus purified whey hydrolysate and manufacturing method thereof |
-
1985
- 1985-05-24 JP JP11052485A patent/JPS61268138A/en active Granted
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02503425A (en) * | 1987-05-14 | 1990-10-18 | コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガナイゼーション | whey protein fraction |
AU616411B2 (en) * | 1987-05-14 | 1991-10-31 | Commonwealth Scientific And Industrial Research Organisation | Whey protein fractions |
JPH0279940A (en) * | 1988-06-16 | 1990-03-20 | Unilever Nv | Endible plastic composition |
US5135869A (en) * | 1988-07-20 | 1992-08-04 | Meiji Milk Products Company Limited | Selective enzymatic degradation of β-lactoglobulin contained in cow's milk-serum protein |
JPH02303457A (en) * | 1989-05-19 | 1990-12-17 | Snow Brand Milk Prod Co Ltd | Food and medicine having osteogenesis promotive and bone resorption preventive effects |
JP2802436B2 (en) * | 1989-05-19 | 1998-09-24 | 雪印乳業株式会社 | Bone disease treatment / prevention agent |
US5093143A (en) * | 1990-01-26 | 1992-03-03 | Milchwerke Westfalen Eg | Dietetic nutrient compositions for patients with kidney insufficiency |
JPH04267850A (en) * | 1991-02-25 | 1992-09-24 | Daiichi Kasei:Kk | Production of processed food of prepared milk serum protein |
JPH05236883A (en) * | 1992-02-18 | 1993-09-17 | Snow Brand Milk Prod Co Ltd | Production of fraction having high alpha-lactoalbumin content from whey and human milk substitute or nutritious composition containing the same fraction |
US5420249A (en) * | 1992-12-23 | 1995-05-30 | Campina Melkunie B.V. | Process for the recovery of α-lactalbumin and β-lactoglobulin from a whey protein product |
WO1995034216A1 (en) * | 1994-06-15 | 1995-12-21 | Pascont Technologies Limited | Process for the fractionation of whey constituents |
CN112770637A (en) * | 2018-06-27 | 2021-05-07 | 阿尔拉食品公司 | Novel method for preparing compositions enriched in alpha-lactalbumin, related products and use in e.g. infant formulas |
Also Published As
Publication number | Publication date |
---|---|
JPH0360468B2 (en) | 1991-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101317037B1 (en) | Powder being rich in milk-origin complex lipids | |
AU664934B2 (en) | Process for the recovery of alpha-lactalbumin and beta-lactoglobulin from a whey protein product | |
JPH02237992A (en) | Production of sialic acids-containing lactose | |
JP4250254B2 (en) | Whey protein concentrate and method for producing the same | |
BR112013022251B1 (en) | METHOD FOR ISOLATING OSTEOPONTIN USING FOODS CONTAINING CMP OR CASEIN SPECIES | |
JPS61268138A (en) | Production of modified whey protein concentrate | |
Maubois | Ultrafiltration of whey | |
JP3035833B2 (en) | Method for producing sialic acids-containing composition | |
JPS6339545A (en) | Method for removing beta-lactoglobulin in milk whey | |
WO2007100264A1 (en) | Dairy product and process | |
JP2961625B2 (en) | Method for producing a composition having a high content of α-lactalbumin | |
JP3929085B2 (en) | Method for producing ganglioside-rich composition | |
AU651148B2 (en) | A process for the manufacture of a milk fraction with a high-alfa-lactalbumin content and a product comprising the same | |
JP3261429B2 (en) | Infant formula similar to human milk | |
Aslam et al. | Recent Developments in Purifi cation Techniques for Whey Valorization | |
JP3176698B2 (en) | Method for producing ganglioside-containing composition | |
DE19950240A1 (en) | Production of high approximately a-lactalbumin content whey protein concentrate useful in foods for infants by heating to ease subsequent separation off of aggregated by- product | |
JP3411965B2 (en) | Method for producing polyamine-containing composition | |
JP2900953B2 (en) | Process for producing a milk fraction having a high content of α-lactalbumin and a product containing the fraction | |
US20020183489A1 (en) | Large scale production of low fat and SDS gel pure kappa-casein glycomacropeptides (GMP) from bovine deproteinzed whey | |
Bazinet | Electrodialysis applications on dairy ingredients separation | |
SU1454347A1 (en) | Method of producing lactose | |
JPH02261343A (en) | Preparation of sialic acids-containing desalted condensed milk and desalted milk powder | |
CN116836257A (en) | Osteopontin purification method | |
Gurjar et al. | Whey Protein Fractionation by Membrane Technology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |